美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bioverativ Inc

104.98

0.0000

成交量：- -

成交額：- -

市值：113.61億

市盈率：38.38

高：104.98

開：104.98

低：104.98

收：104.98

52周最高：104.98

52周最低：48.14

股本：1.08億

流通股本：1.08億

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):2.74

淨資產收益率：--

總資產收益率：--

市淨率：12.66

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Bioverativ Inc

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.bioverativ.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Bioverativ Inc.在美國特拉華州註冊成立於2016年8月4日。Bioverativ是一家全球性生物技術公司，專註於為血友病等血液疾病的治療發現，研究，開發和商業化的創新療法。Bioverativ市場有兩款產品，ELOCTATE [抗血友病因子（重組），Fc融合蛋白]和ALPROLIX [凝血因子IX（重組），Fc融合蛋白]，分別用來延長半衰期凝血因子從而針對血友病A和B型血友病的治療。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BIVV/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIVV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIVV\",,,,,undefined,":{"symbol":"BIVV","market":"US","secType":"STK","nameCN":"Bioverativ Inc","latestPrice":104.98,"timestamp":1520542800000,"preClose":104.98,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":107952000,"shares":108223644,"eps":2.7352,"marketStatus":"停牌","change":0,"latestTime":"03-27 15:07:15 EDT","open":104.98,"high":104.98,"low":104.98,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.7352,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774641600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":104.98,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIVV\",,,,,undefined,":{"symbol":"BIVV","floatShares":107952000,"roa":"--","roe":"--","lyrEps":0,"shares":108223644,"dividePrice":0,"high":104.98,"amplitude":0,"preClose":104.98,"low":104.98,"week52Low":48.14,"pbRate":"12.66","week52High":104.98,"institutionHeld":0,"latestPrice":104.98,"eps":2.7352,"divideRate":0,"volume":0,"delay":0,"ttmEps":2.7352,"open":104.98,"prevYearClose":104.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIVV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-02-13","symbol":"BIVV","fiscalQuarterEnding":"2017/12","expectedEps":0.75,"name":null,"time":"盤後","type":"earning","dateTimestamp":1518498000000,"reportTimeType":"post","actualEps":0.76},{"market":"US","date":"2017-10-26","symbol":"BIVV","fiscalQuarterEnding":"2017/09","expectedEps":0.55,"name":null,"time":"盤後","type":"earning","dateTimestamp":1508990400000,"reportTimeType":"post","actualEps":0.63},{"market":"US","date":"2017-08-02","symbol":"BIVV","fiscalQuarterEnding":"2017/06","expectedEps":0.64,"name":null,"time":"盤後","type":"earning","dateTimestamp":1501646400000,"reportTimeType":"post","actualEps":0.71},{"market":"US","date":"2017-05-03","symbol":"BIVV","fiscalQuarterEnding":"2017/03","expectedEps":0.62,"name":null,"time":"盤後","type":"earning","dateTimestamp":1493784000000,"reportTimeType":"post","actualEps":0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIVV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIVV\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.bioverativ.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0615},{"period":"3month","weight":-0.0655},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1345},{"period":"ytd","weight":-0.054}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Bioverativ Inc.在美國特拉華州註冊成立於2016年8月4日。Bioverativ是一家全球性生物技術公司，專註於為血友病等血液疾病的治療發現，研究，開發和商業化的創新療法。Bioverativ市場有兩款產品，ELOCTATE [抗血友病因子（重組），Fc融合蛋白]和ALPROLIX [凝血因子IX（重組），Fc融合蛋白]，分別用來延長半衰期凝血因子從而針對血友病A和B型血友病的治療。","exchange":"NASDAQ","name":"Bioverativ Inc","nameEN":"Bioverativ Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BIVV\",market:\"US\",,,undefined,":null}}